Overall rank by patents
#25,967
Across all tracked assignees
USPTO PatentsView assignee record - 10 granted patents across 11 technology areas, active 2015–2019. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES).
The verdict
Chromocell holds 10 US patents across 11 technology areas, rank #25,967 of 50,000 tracked assignees.
Chromocell Corporation has been granted 10 US utility patents between 2015 and 2019, placing Chromocell Corporation at rank #25,967 across all assignees tracked by PlainPatent. This portfolio spans 11 distinct Cooperative Patent Classification (CPC) subclasses, averaging 28.4 claims per patent with primary concentration in G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES). As a US Corporation, Chromocell Corporation is one of the more focused assignees in the PatentsView dataset. By volume, Chromocell sits between Chian YIH Optotech Co., Ltd. (10 patents, rank #25,963) and Cinemo Gmbh (10 patents, rank #25,971) - the closest US assignees by grant volume. The composite Innovation Score of 35.0/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 0 grants, compared with 10 in the 2015–2019 window, a -100% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Chromocell Corporation's 28.4 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while concentration in 11 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Chromocell Corporation against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
CHIAN YIH OPTOTECH CO., LTD.
10 patents
CHINA FLASH CO., LTD.
10 patents
CHISCAN HOLDINGS, LLC
10 patents
CHOL, Inc.
10 patents
CHS, Inc.
10 patents
CHUO UNIVERSITY
10 patents
CICABOOM S.r.L
10 patents
CINEMO GMBH
10 patents
CHROMOCELL CORPORATION
10 patents
What this shows Chromocell holds 10 patents at rank #25,967, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Chromocell's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
35 Top 50% higher than 50% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 1 | 10.0% |
| 2016 | 3 | 30.0% |
| 2017 | 3 | 30.0% |
| 2018 | 2 | 20.0% |
| 2019 | 1 | 10.0% |
Top 11 of 11 technology areas
Overall rank by patents
#25,967
Across all tracked assignees
35.0 out of 100
How to use this portfolio
Chromocell's 10 grants land it in the top 50% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.